A detailed history of Walter & Keenan Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Walter & Keenan Wealth Management LLC holds 9,750 shares of BMY stock, worth $567,742. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,750
Previous 9,996 2.46%
Holding current value
$567,742
Previous $415,000 21.45%
% of portfolio
0.15%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$39.66 - $51.75 $9,756 - $12,730
-246 Reduced 2.46%
9,750 $504,000
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $8,452 - $11,127
-210 Reduced 2.06%
9,996 $415,000
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $54,793 - $62,124
1,142 Added 12.6%
10,206 $553,000
Q4 2023

Jan 25, 2024

SELL
$48.48 - $57.85 $33,936 - $40,495
-700 Reduced 7.17%
9,064 $465,000
Q3 2023

Oct 20, 2023

BUY
$57.89 - $64.73 $2,257 - $2,524
39 Added 0.4%
9,764 $566,000
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $4,778 - $5,305
75 Added 0.78%
9,725 $621,000
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $361,404 - $409,915
-5,500 Reduced 36.3%
9,650 $668,000
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $37,664 - $44,599
550 Added 3.77%
15,150 $1.09 Million
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $65 - $38,727
504 Added 3.58%
14,600 $1.04 Million
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $30,863 - $33,991
-425 Reduced 2.93%
14,096 $1.09 Million
Q3 2021

Oct 18, 2021

BUY
$59.17 - $69.31 $55,915 - $65,497
945 Added 6.96%
14,521 $859,000
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $196,564 - $214,058
3,175 Added 30.53%
13,576 $907,000
Q1 2021

Apr 30, 2021

SELL
$59.34 - $66.74 $47,472 - $53,391
-800 Reduced 7.14%
10,401 $657,000
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $5,774 - $6,543
100 Added 0.9%
11,201 $695,000
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $2,641 - $2,927
-46 Reduced 0.41%
11,101 $669,000
Q2 2020

Jul 16, 2020

BUY
$54.82 - $64.09 $611,078 - $714,411
11,147 New
11,147 $655,000
Q1 2020

Apr 14, 2020

SELL
$46.4 - $67.43 $515,086 - $748,540
-11,101 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $18,699 - $24,392
380 Added 3.54%
11,101 $713,000
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $67,148 - $79,614
1,570 Added 17.16%
10,721 $544,000
Q2 2019

Aug 01, 2019

BUY
$44.62 - $49.34 $22,310 - $24,670
500 Added 5.78%
9,151 $415,000
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $9,069 - $10,813
201 Added 2.38%
8,651 $413,000
Q3 2018

Oct 29, 2018

SELL
$55.19 - $62.25 $8,278 - $9,337
-150 Reduced 1.74%
8,450 $525,000
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $7,579 - $9,447
150 Added 1.78%
8,600 $476,000
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $466,693 - $538,603
8,450
8,450 $559,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Walter & Keenan Wealth Management LLC Portfolio

Follow Walter & Keenan Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walter & Keenan Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Walter & Keenan Wealth Management LLC with notifications on news.